Home Drug development Publications Efficacy and Safety Of AFN-125…

Efficacy and Safety Of AFN-1252, The First Staphylococcus-Specific Antibacterial Agent, in The Treatment of Acute Bacterial Skin And Skin Structure Infections, Including Those in Patients With Significant Comorbidities

B. Hafkin (1), N. Kaplan (1), B. Murphy (2)

Antimicrob Agents Chemother. 2016 Mar; 60(3): 1695–1701.

Nobelex Biotech, Toronto, Ontario, Canada
Medpace, Inc., Cincinnati, Ohio, USA